<DOC>
	<DOCNO>NCT01706861</DOCNO>
	<brief_summary>The objective study actively gather additional information safety , device performance possible emergent risk follow use Celotres post-market setting use reduce recurrence rate , volume , appearance and/or symptom associate keloid scar subject undergoing surgical excision keloid compare scientific literature .</brief_summary>
	<brief_title>A Post Market Study Evaluating Safety , Device Perfomance Possible Emergent Risks Celotres Preventing Recurrence Keloid Lesions Treated Adjunctive Surgical Excision</brief_title>
	<detailed_description />
	<mesh_term>Recurrence</mesh_term>
	<mesh_term>Keloid</mesh_term>
	<criteria>Patients elect undergo keloid excision procedure Patients able willing give write informed consent Patients know potential risk allergy sensitivity product substance contain porcine gelatin .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2014</verification_date>
</DOC>